CoChat

Presence of Banned Drugs in Dietary Supplements Following FDA Recalls

Open access
Cohen, Pieter A., Maller, Gregory, DeSouza, Renan, Neal-Kababick, James · 2014 · JAMA
Cited by 100

The DOI matches its Crossref record.

Abstract

Presence of Banned Drugs in Dietary Supplements Following FDA Recalls The US Food and Drug Administration (FDA) initiates class I drug recalls when products have the reasonable possibility of causing serious adverse health consequences or death.1 Recently, the FDA has used class I drug recalls in an effort to remove dietary supplements adulterated with pharmaceutical ingredients from US markets. Approximately half of all FDA class I drug recalls since 2004 have involved dietary supplements adulterated with banned pharmaceutical ingredients.2,3 Prior research has found that even after FDA recalls, dietary supplements remain available on store shelves.4 However, it is not known if the supplements on sale after FDA recalls are free of the adulterants. In the present study, dietary supplements purchased at least 6 months after FDA recalls were analyzed to determine if banned drugs were still present.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jama.2014.10308

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 100

Metadata

Authors
Cohen, P. A., Maller, G., DeSouza, R., & Neal-Kababick, J.
Venue
JAMA
Published
2014-10-22
Volume
312
Issue
16
Pages
1691
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W2066092622
Cited by
100
References
0
FWCI
11.34
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Presence of Banned Drugs in Dietary Supplements Following FDA Recalls. https://app.cochat.ai/papers/10.1001/jama.2014.10308
The paper
Cohen, P. A., Maller, G., DeSouza, R., & Neal-Kababick, J. (2014). Presence of Banned Drugs in Dietary Supplements Following FDA Recalls. JAMA. https://doi.org/10.1001/jama.2014.10308

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.